| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 41.491 | 69.268 | 86.943 | 70.686 | 74.673 | 79.314 | 80.625 |
| Total Income - EUR | - | - | - | 41.491 | 69.268 | 87.284 | 70.686 | 74.673 | 79.314 | 80.850 |
| Total Expenses - EUR | - | - | - | 34.462 | 59.122 | 72.717 | 160.510 | 63.396 | 62.742 | 59.859 |
| Gross Profit/Loss - EUR | - | - | - | 7.029 | 10.146 | 14.567 | -89.824 | 11.277 | 16.572 | 20.991 |
| Net Profit/Loss - EUR | - | - | - | 6.614 | 9.453 | 13.694 | -90.531 | 10.530 | 13.893 | 17.513 |
| Employees | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Excelent Fitofarm Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 12.786 | 9.440 | 6.398 | 3.317 | 3.889 |
| Current Assets | - | - | - | 25.009 | 95.687 | 128.559 | 45.947 | 60.655 | 80.271 | 97.519 |
| Inventories | - | - | - | 24.082 | 89.138 | 120.852 | 43.051 | 57.546 | 73.965 | 83.155 |
| Receivables | - | - | - | 921 | 6.543 | 7.694 | 2.875 | 3.072 | 4.866 | 5.274 |
| Cash | - | - | - | 5 | 7 | 13 | 21 | 37 | 1.440 | 9.089 |
| Shareholders Funds | - | - | - | 6.657 | 15.981 | 32.466 | -58.785 | -48.437 | -35.205 | -17.495 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 18.352 | 79.706 | 108.878 | 114.172 | 115.490 | 118.793 | 118.903 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4776 - 4776" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Excelent Fitofarm Bio S.r.l.